Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ)
CNY 7.43
(-9.06%)
CNY 7.43
(-9.06%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - CNY | 0.0% |
| 2022 | - CNY | -100.0% |
| 2021 | 1.00 CNY | 0.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | -100.0% |
| 2010 | 7.5 Million CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| 2004 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - CNY | 0.0% |
| 2024 Q1 | - CNY | 0.0% |
| 2024 Q3 | - CNY | 0.0% |
| 2023 FY | - CNY | 0.0% |
| 2023 Q4 | - CNY | 0.0% |
| 2023 Q1 | - CNY | 0.0% |
| 2023 Q2 | 1.00 CNY | 13421772800.0% |
| 2023 Q3 | - CNY | -100.0% |
| 2022 Q2 | - CNY | 0.0% |
| 2022 Q1 | - CNY | -100.0% |
| 2022 Q3 | - CNY | 0.0% |
| 2022 Q4 | - CNY | 0.0% |
| 2022 FY | - CNY | -100.0% |
| 2021 Q4 | 1.00 CNY | 0.0% |
| 2021 Q3 | 1.00 CNY | 0.0% |
| 2021 Q2 | 1.00 CNY | 13421772800.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 FY | 1.00 CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2018 Q3 | 1.00 CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q4 | - CNY | -100.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 Q3 | 11.5 Million CNY | 0.0% |
| 2013 Q4 | - CNY | -100.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2012 Q3 | - CNY | -100.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q2 | 9.8 Million CNY | 78.18% |
| 2012 Q1 | 5.5 Million CNY | 0.0% |
| 2011 Q3 | 30 Million CNY | 0.0% |
| 2011 FY | - CNY | -100.0% |
| 2011 Q4 | - CNY | -100.0% |
| 2011 Q1 | 22.5 Million CNY | 200.0% |
| 2011 Q2 | 30 Million CNY | 33.33% |
| 2010 Q1 | - CNY | 0.0% |
| 2010 Q4 | 7.5 Million CNY | -75.0% |
| 2010 Q3 | 30 Million CNY | 50.0% |
| 2010 Q2 | 20 Million CNY | 0.0% |
| 2010 FY | 7.5 Million CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 Q3 | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2009 Q1 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2008 Q1 | - CNY | 0.0% |
| 2008 Q2 | - CNY | 0.0% |
| 2008 Q3 | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2007 Q4 | - CNY | 0.0% |
| 2007 Q2 | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2007 Q3 | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2006 Q4 | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |
| 2004 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 671.68 Million CNY | 100.0% |
| Zhejiang Zhenyuan Share Co., Ltd. | 54.96 Million CNY | 100.0% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 94.96 Million CNY | 100.0% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 419.53 Million CNY | 100.0% |
| Yifan Pharmaceutical Co., Ltd. | 812.04 Million CNY | 100.0% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.64 Billion CNY | 100.0% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 126.5 Million CNY | 100.0% |
| Boai NKY Medical Holdings Ltd. | 32.61 Million CNY | 100.0% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 21.25 Million CNY | 100.0% |